RE: Up 86p11 Nov 2020 11:11
The Company notes the fast changing situation regarding possible COVID-19 vaccines. The widely reported and very positive interim trial results of a vaccine developed by Pfizer and BioNTech are hugely encouraging and welcomed by everyone. However, the Directors believe that the roll out of a vaccine will not lessen in the near term demand for its developing viricidal mask product. The Directors also note and welcome the new Scientific Brief released yesterday by the US Centre for Disease Control* expanding on the benefits of masks for both the wearer and the community.
----
see this going higher in the next few weeks